RXi Pharmaceuticals Corporation
60 Prescott Street
Worcester,
MA 01605
United States - Map
Phone: 508-767-3861
Fax: 508-767-3862
Website: http://www.rxipharma.com
| Index Membership: | N/A | | Sector: | Healthcare | | Industry: | Drug Manufacturers - Major | | Full Time Employees: | 10 |
|
RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform. It provides RXI-109, a self-delivering RNAi compound (sd-rxRNA) for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin. The company was founded in 2011 and is based in Worcester, Massachusetts. RXi Pharmaceuticals Corporation operates as a subsidiary of Galena Biopharma, Inc. Key Statistics
| |
| | Pay | Exercised | Dr. Geert Cauwenbergh Ph.D., Med.Sc.,
59
Chief Exec. Officer, Pres, Chief Financial Officer and Director | 237.00k | 0.00 | Dr. Pamela J. Pavco Ph.D.,
57
Chief Devel. Officer | 300.00k | 0.00 | Dr. Craig C. Mello Ph.D.,
Founder and Chairman of Scientific Advisory Board | N/A | N/A | Dr. Tod M. Woolf Ph.D.,
48
Founder and Member of Scientific Advisory Board | N/A | N/A | Ms. Caitlin Kontulis ,
27
Principal Accounting Officer, Controller and Sec. | N/A | N/A |
|
| | Amounts are as of 2012-12-30 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.84%